Skip to main content
. Author manuscript; available in PMC: 2015 Oct 22.
Published in final edited form as: Mol Pharm. 2015 Jul 10;12(8):3032–3042. doi: 10.1021/acs.molpharmaceut.5b00297

Figure 3.

Figure 3

MTS assay using hADMSCs analyzing the cytotoxicity of PEI/pDNA complexes at N/P ratios of 5 and 10 and at 1 μg and 5 μg of pDNA. Significant differences between the treatments and untreated cells were assessed by one way ANOVA followed by Tukey’s post-test (**p<0.01). Values are expressed as mean ± SEM.